Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MACRO: Olanzapine for Anorexia During Chemoradiation in Head and Neck Cancer
NCT06995508Phase 2Recruiting
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Dec 2025
- Primary completion
- Nov 2030
- Countries
- 1
01
Overview
A Phase 2 trial of olanzapine in cancer-associated anorexia, sponsored by Roswell Park Comprehensive Cancer Center. Started Dec 2025; status: recruiting.
02
Drugs
olanzapine
03
Conditions
cancer-associated anorexia
Beyond the preview
Go deeper on NCT06995508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06995508.